Front | Back |
Acetylcholine
|
Neurotransmitter of the PSNS
|
Acetylcholinersterase
|
The enzyme responsible for breaking down acetylcholine
|
Nicotinic receptors
|
Located in the ganglia of both PSNS and SNS, stimulated by alkaloid nicotine
|
Muscarininc receptor
|
Located postsynaptically in the effect organs of the PSNS, stimulated by the alkaloid muscarine
|
Direct-binding cholinergic agonists
|
Bind to cholinergic receptors, activating them
|
Indirect-acting cholinergic agonists
|
Inhibit the enzyme acetylcholinerstase, which breaks down ACh
|
Reversible
|
Bind to cholinesterase for a period of a few minutes to hours
|
Irreversible
|
Bind to cholinesterase and form a permanent covalent bond
|
Miosis
|
Constriction of the pupil
|
Alzheimer's treatment
|
Acetylcholine effects and stimulates muscarinic receptors - donepezil (Aricept)
|
Donepezil (Aricept)
|
Indirect-acting cholinergic drug used to treat Alzheimer's
|
Bethanechol
|
Direct-acting cholinergic used to treat urinary retention
|
In-direct acting drugs
|
Drugs that cause skeletal muscle contraction
|
Myasthenia gravis
|
Muscle disease that breaks down the acetylcholine resulting in muscle weakness
|
Adverse effects of cholinergics
|
Result of overstimulation of the PSNS
|